Skip to main navigation
Syndax Pharmaceuticals, Inc. logo
  • About Us
    • About Us
    • Leadership
    • Board of Directors
    • Patient Community
  • Focus Areas
    • Focus Areas
    • KMT2Ar Acute Leukemias
    • NPM1m Acute Myeloid Leukemia
    • Chronic Graft-Versus-Host Disease
  • Pipeline
    • Pipeline
    • Menin Inhibitor
    • Anti-CSF-1R Monoclonal Antibody
    • Entinostat
    • Publications & Meeting Presentations
  • Our Products
  • Patients
    • Patients
    • Managed Access Programs
  • Investors
  • Careers
  • News
  • Contact Us

Board of Directors

Investors
  • Home
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Governance Overview
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financial Information
    • Financial Overview
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
    • Analyst Consensus
  • Shareholder Services
    • Investor FAQs
    • Contact Us
    • RSS Feeds
    • Email Alerts
Dennis G. Podlesak
Chair of the Board of Directors
Full Bio
Michael A. Metzger
Chief Executive Officer and Director
Full Bio
Martin H. Huber, M.D.
Director
Full Bio
Jennifer Jarrett
Director
Full Bio
Keith A. Katkin
Director
Full Bio
Pierre Legault
Director
Full Bio
Aleksandra Rizo, M.D., Ph.D.
Director
Full Bio
Syndax Pharmaceuticals, Inc. logo
  • About Us
  • Focus Areas
  • Pipeline
  • Our Products
  • Patients
  • Investors
  • Careers
  • News
  • Contact Us
Privacy Notice
Cookie Notice
Consumer Health Data Supplemental Privacy Notice
State Regulations
Terms of Use
Limit the Use of My Personal Information
© 2026 Syndax Pharmaceuticals, Inc.
linkedin x.com glassdoor